Immune cell therapies that include CAR-T cells represent a breakthrough in the treatment of haematologic malignancies and are promising in numerous medical fields.
The Cellular Immunotherapy Club, created in 2020 and affiliated to the SFI, brings together immunologists studying the fundamental aspects of CAR-T cell biology (e.g. signal transduction) and researchers and clinicians involved in development and immunomonitoring cellular immunotherapies.
The Club is meant to connect researchers and clinicians of the SFI with those of the societies of specialties where immune cell therapies are utilized or being in development stages, mainly haematology and oncology but also transplantation and clinical immunology. This will be achieved through scientific events that will be co-organized by the Club together with those societies.
Its purpose is to promote immune cell therapy as a major development axis in immunology
The first event of the Cellular Immunotherapy Club took place on Wednesday December 8, 2021 during the Annual Congress of the SFI, Cité des Sciences et de l’Industrie, Paris. The three best abstracts selected for an oral presentation were awarded with the ITcell Miltenyi Prize.
Club Events :
8th International Symposium on CAR T cells (CAR T Day), October 17-18, 2024 Lille, France
Article
« Joint meeting SFI & DGfI » organized by the French Society of Immunology (Société Françaised’Immunologie – SFI) et the German Society for Immunology (Deutsche Gesellschaft fürImmunologie – DGfI), 26-29 September 2023, Strasbourg, France.
A feedback from the « Cancer Immunology » plenary session.
